Unisphere Establishment trimmed its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 44.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 322,500 shares of the company's stock after selling 257,500 shares during the quarter. Unisphere Establishment owned 0.19% of BrightSpring Health Services worth $5,492,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. FMR LLC lifted its position in BrightSpring Health Services by 21.6% during the 4th quarter. FMR LLC now owns 22,102,490 shares of the company's stock worth $376,405,000 after acquiring an additional 3,933,303 shares during the last quarter. T. Rowe Price Investment Management Inc. bought a new position in BrightSpring Health Services in the 4th quarter worth approximately $26,958,000. Norges Bank acquired a new position in shares of BrightSpring Health Services during the fourth quarter worth approximately $26,065,000. Raymond James Financial Inc. acquired a new stake in shares of BrightSpring Health Services in the fourth quarter worth $18,257,000. Finally, Renaissance Technologies LLC raised its stake in BrightSpring Health Services by 205.6% during the 4th quarter. Renaissance Technologies LLC now owns 557,700 shares of the company's stock valued at $9,498,000 after purchasing an additional 375,200 shares during the last quarter.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on the stock. Mizuho set a $26.00 target price on shares of BrightSpring Health Services in a research note on Monday. UBS Group boosted their price target on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. One equities research analyst has rated the stock with a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $22.33.
View Our Latest Report on BTSG
BrightSpring Health Services Price Performance
Shares of NASDAQ:BTSG traded up $0.12 on Monday, hitting $20.99. The stock had a trading volume of 1,593,372 shares, compared to its average volume of 1,304,718. The company has a market capitalization of $3.68 billion, a price-to-earnings ratio of -80.62 and a beta of 2.02. BrightSpring Health Services, Inc. has a twelve month low of $10.15 and a twelve month high of $24.82. The firm's 50 day moving average price is $17.62 and its 200-day moving average price is $18.52. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its earnings results on Friday, May 2nd. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.09 by $0.10. The company had revenue of $2.88 billion during the quarter, compared to analysts' expectations of $2.74 billion. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The business's revenue for the quarter was up 25.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.12 EPS. On average, equities research analysts predict that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current year.
About BrightSpring Health Services
(
Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
See Also

Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.